Nelson’s Syndrome: Complete Remission with Cabergoline but Not with Bromocriptine or Cyproheptadine Treatment

Publisher： Karger

E-ISSN： 1663-2826|62|6|300-305

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.62, Iss.6, 2004-12, pp. : 300-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medical Treatment in Cushing’s Syndrome: Dopamine Agonists and Cabergoline

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 116-119

Karger

Access to resources Recommend Favorite

Biliopancreatic Diversion with Duodenal Switch in Patients with Type 2 Diabetes mellitus: Is the Chance of Complete Remission Dependent on Therapy and Duration of Insulin Treatment?

By  

Obesity Facts, Vol. 4, Iss. 1, 2011-03 ,pp. : 18-23

Karger

Access to resources Recommend Favorite

Hypertension in Cushing’s Syndrome: From Pathogenesis to Treatment

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 44-49

Karger

Access to resources Recommend Favorite

Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas

By  

Neuroendocrinology, Vol. 101, Iss. 1, 2015-01 ,pp. : 66-81

Karger

Access to resources Recommend Favorite

Complete Clinical Remission and Disappearance of Liver Metastases after Treatment with Somatostatin Analogue in a 40-Year-Old Woman with a Malignant Insulinoma Positive for Somatostatin Receptors Type 2

By  

Hormone Research in Paediatrics, Vol. 65, Iss. 3, 2006-03 ,pp. : 120-125

Karger

Access to resources Recommend Favorite